Investments
Commented by André Will-Laudien on December 22nd, 2022 | 11:18 CET
Christmas hype alert: BASF, Meta Materials, Varta, Nordex - Strong start to 2023 with GreenTech!
Fossil energy supply is becoming more and more expensive. The political end of the supplier and raw material giant Russia creates a dangerous undersupply, especially for Central Europe. The current winter, but especially the next one, could pose problems, and the industry will probably have to calculate significantly higher input costs in the medium term. Products are becoming considerably more expensive to produce, so selling prices on the shelves are also increasing. The inflationary spiral will thus continue to spiral upward, and consumers' purchasing power will decline. GreenTech solutions are more in demand than ever for the purchase of low-cost energy. So which stocks to watch out for?
Read
Commented by Fabian Lorenz on December 21st, 2022 | 08:48 CET
BASF, BioNTech, Cardiol Therapeutics: Stocks for 2023?
Is there a 400% upside potential in 2023? At the end of a challenging 2022 stock market year, we are looking ahead to the new year. Which share is worth buying, and which is better left alone? In the case of BASF, the high dividend yield is one of the attractions. The latest company news shows that the chemical group is also involved in the mega market of electromobility. But the dependence on gas supplies is causing uncertainty, and an analyst has renewed a sell recommendation for BASF shares. BioNTech, on the other hand, is looking good, even if the chart picture has recently clouded over. The development pipeline is full, capacities - especially in Asia - are being expanded, and analysts are also more courageous again. Investors also need a little courage and, above all, patience with Cardiol Therapeutics. They could soon be rewarded. The cash position of the biotech pearl is almost equal to the market capitalization, the main product is already in the Phase 2 pilot study, and analysts see massive upside potential.
Read
Commented by André Will-Laudien on December 21st, 2022 | 08:46 CET
The best cards for 2023: Amazon, Aspermont, flatexDEGIRO, TUI - Which stock will take off?
Crisis, crisis, crisis - we do not want to hear any more about it at Christmas time. After the relief rally, the stock markets have gone back to sleep. It was turbulent until September, and then the correction was over for the time being. But how much "good" is already priced in for next year? Will there be a quick end to the war, can the inflation rate also fall, and what will interest rates do in 2023? Many unanswered questions that will likely only be answered gradually. The shares have to achieve a fair valuation from this mixed situation - perhaps that is why the correction is not quite over yet. Where are the best opportunities for investors?
Read
Commented by Stefan Feulner on December 20th, 2022 | 11:43 CET
Analysts optimistic for oil stocks - TotalEnergies, Saturn Oil + Gas, BP
High volatility characterized the oil markets in 2022, a stock market year that will soon come to an end. While oil prices for West Texas Intermediate, WTI, reached over USD 130 per barrel after the outbreak of the Ukraine conflict, the black gold subsequently corrected by more than 40% due to heightened fears of recession. In the long term, analysts agree that oil prices will likely rise significantly due to increased demand and tight supply.
Read
Commented by André Will-Laudien on December 15th, 2022 | 12:09 CET
100% turnaround opportunities for 2023: TUI, Uniper, Desert Gold, FlatexDEGIRO - The New Year's Eve bangers!
Despite all the gloom, the capital market offers plenty of new opportunities every day. Although the DAX is holding up well at the end of the year, many shares have crashed and remain at the bottom of the charts for the time being. But there are some glimmers of hope. Many investors sell poorly performing shares at the end of the year in order to benefit from the tax write-off of losses. The lucky investors even have a few profits to offset and like to smooth out the underperformers at year-end. Shares in Uniper, TUI and FlatexDEGIRO have slumped between 40% and 90% this year, but there are bright spots for 2023.
Read
Commented by Fabian Lorenz on December 15th, 2022 | 12:05 CET
E-car boom in Germany: BYD, Plug Power and dynaCERT are profiteers of the energy transition
The trend toward e-cars continues. In November 2022, 260,512 passenger cars were newly registered in Germany (source: kba.de). That represents an increase of 31% compared to the previous year. New registrations of electric passenger cars (BEV) increased disproportionately by 44% to 57,980 units. Significantly, Tesla's Model 3 was the most-registered car in the mid-size segment, while the Porsche Taycan was the most-registered car in the luxury segment - across all drive types. The trend toward electromobility should continue in the coming year. That is also when BYD plans to shake up the market in Europe. As a result, the excitement for shareholders is rising. The same applies to Plug Power and dynaCERT. Both are facing milestones in 2023 that should catapult share prices to new heights.
Read
Commented by Nico Popp on December 15th, 2022 | 10:48 CET
Gold Rally! Why precious metals offer themselves now: Barrick Gold, Tocvan Ventures, Steinhoff
Especially during uncertain stock market times, it pays to keep an eye on various asset classes. One of them, namely gold, has recently delivered the first rally signals. In this article, we outline what this means for investors and why precious metals are not a question of faith. What are the alternatives to gold, and what stocks offer opportunities now?
Read
Commented by Nico Popp on December 14th, 2022 | 11:58 CET
Hydrogen: Where things get tight, where opportunities lurk - NEL, First Hydrogen, Amazon
Hydrogen is picking up speed! In northern Germany, the first hydrogen trains recently went into regular service. At the same time, decision-makers from Spain, France and Portugal are working with the EU on a hydrogen pipeline from Barcelona to Marseille. From 2030, green hydrogen should also flow indirectly through this pipeline to Germany. We present companies that could benefit and are already setting the course for tomorrow.
Read
Commented by Stefan Feulner on December 13th, 2022 | 10:43 CET
Rheinmetall, Aspermont, BioNTech - Strong momentum
With its many drastic events, the turbulent stock market year 2022 is drawing to a close. With the Ukraine war, the change in monetary policy by central banks and rampant inflation, the year was characterized by strong uncertainty and high volatility, and it is almost certain to continue in the coming year. Nevertheless, the favourites are emerging more and more clearly from various sectors that should outperform the broad market in the months ahead.
Read
Commented by Armin Schulz on December 12th, 2022 | 10:20 CET
BioNTech, va-Q-tec, Cardiol Therapeutics, Ambrx Biopharma - Biotech second-line stocks explode
For investors in biotech stocks, 2022 was often a year to forget. After the Corona hype, the market clouded over significantly, in part due to rising interest rates. December is the time of year when investors can make adjustments to their portfolio, thereby reducing their tax burden for the year ahead. This year is no exception, yet three stocks shot up last Friday. That is unusual during tax loss season. We look at the three high flyers and BioNTech, a big player in the biotech sector.
Read